Copyright
©The Author(s) 2016.
World J Gastroenterol. Oct 28, 2016; 22(40): 8956-8966
Published online Oct 28, 2016. doi: 10.3748/wjg.v22.i40.8956
Published online Oct 28, 2016. doi: 10.3748/wjg.v22.i40.8956
Figure 2 G1-G3 neuroendocrine neoplasms.
A: G1 - tumor with trabecular and nested pattern (H&E × 200); B: Tumor cells displaying Ki-67 index of < 1% (immunohistochemistry × 200); C: G2 - tumor with gyriform and festooning patterns and the tumor cells display mildly pleomorphic nuclei with coarse stippled chromatin (H&E × 200); D: Tumor cells displaying Ki-67 index of approximately 16% (immunohistochemistry × 200); E: G3 - tumor cells with pleomorphic and hyperchromatic nuclei displaying brisk mitotic (arrow) and apoptotic activity and focal necrosis (arrow head) (H&E × 200); F: Tumor cells displaying Ki-67 index of approximately 80% (immunohistochemistry × 200); G: Tumor cells displaying diffuse cytoplasmic positivity for synaptophysin (immunohistochemistry × 200); H: Tumor cells displaying diffuse cytoplasmic positivity for chromogranin (immunohistochemistry × 200).
- Citation: Burad DK, Kodiatte TA, Rajeeb SM, Goel A, Eapen CE, Ramakrishna B. Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification. World J Gastroenterol 2016; 22(40): 8956-8966
- URL: https://www.wjgnet.com/1007-9327/full/v22/i40/8956.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i40.8956